Italian investment bank Mediobanca SpA (MB.MI) has increased its stake in biotechnology firm Crucell NV (CXRL.AE) to 5.51%, Dutch market regulator AFM said Friday.

The move takes Mediobanca's stake above the 5% regulatory threshold, requiring it to disclose the size of its stake.

Later Friday afternoon, Crucell will hold an extraordinary shareholders meeting in Amsterdam to discuss Johnson & Johnson's (JNJ) bid of EUR24.75 a share to take over the Dutch biotechnology company. J&J launched a bid for Crucell Wednesday, totaling EUR1.75 billion, for the stake it doesn't already own. The U.S. drug maker already holds about 17.9% of Crucell shares.

At 0936 GMT, Crucell shares were down 0.08% at EUR23.93.

-By Roberta Cowan, Dow Jones Newswires; +3120-571-5200; roberta.cowan@dowjones.com
Crucell NV ADS, Each Representing One Ordinary Share (MM) (NASDAQ:CRXL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Crucell NV ADS, Each Representing One Ordinary Share (MM).
Crucell NV ADS, Each Representing One Ordinary Share (MM) (NASDAQ:CRXL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Crucell NV ADS, Each Representing One Ordinary Share (MM).